Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Timmermans, MA"'
Autor:
van der Loos, MLM, Mulder, PGH (Paul), Hartong, EGTM, Blom, MBJ, Vergouwen, AC, van Noorden, MS, Timmermans, MA, Vieta, E, Nolen, WA
Publikováno v:
Bipolar Disorders, 13(1), 111-117. Blackwell Publishing
Objective: In two previous manuscripts, we described the efficacy of lamotrigine versus placebo as add-on to lithium (followed by the addition of paroxetine in nonresponders) in the short-term treatment of bipolar depression. In this paper we describ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::93793bd231731cbcb3a903bf25c2f2a6
https://pure.eur.nl/en/publications/68295573-1946-4d06-84f7-8d335410588c
https://pure.eur.nl/en/publications/68295573-1946-4d06-84f7-8d335410588c
Autor:
de Kruijff IE; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Onstenk W; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jager A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands., de Jongh FE; Department of Medical Oncology, Ikazia Ziekenhuis, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Kraan J; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Timmermans MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2019 Aug 15; Vol. 145 (4), pp. 1083-1089. Date of Electronic Publication: 2019 Feb 27.
Autor:
Koedoot E; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Fokkelman M; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Rogkoti VM; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Smid M; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3008 AE, Netherlands., van de Sandt I; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., de Bont H; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Pont C; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Klip JE; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Wink S; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Timmermans MA; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3008 AE, Netherlands., Wiemer EAC; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3008 AE, Netherlands., Stoilov P; Department of Biochemistry and Cancer Institute, Robert C. Byrd Health Sciences Center, West Virginia University, Morgantown, WV, 26506, USA., Foekens JA; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3008 AE, Netherlands., Le Dévédec SE; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands., Martens JWM; Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, 3008 AE, Netherlands., van de Water B; Division of Drug Discovery and Safety, LACDR, Leiden University, Einsteinweg 55, Leiden, 2333 CC, Netherlands. b.water@lacdr.leidenuniv.nl.
Publikováno v:
Nature communications [Nat Commun] 2019 Jul 05; Vol. 10 (1), pp. 2983. Date of Electronic Publication: 2019 Jul 05.
Autor:
De Marchi T; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. tommaso.de_marchi@med.lu.se., Timmermans MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Look MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Grebenchtchikov N; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Sweep FCGJ; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Smits JG; Department of Pathology, Admiraal de Ruyter Hospital, Goes, The Netherlands., Magdolen V; Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany., van Deurzen CHM; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Umar A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. j.martens@erasmusmc.nl.; Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. j.martens@erasmusmc.nl.
Publikováno v:
Scientific reports [Sci Rep] 2017 May 18; Vol. 7 (1), pp. 2099. Date of Electronic Publication: 2017 May 18.
Autor:
Braakman RB; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Stingl C; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands., Tilanus-Linthorst MM; Department of Surgery, Erasmus University Medical Center, Rotterdam, the Netherlands., van Deurzen CH; Department of Pathology, Erasmus University Medical Center, Rotterdam, the Netherlands., Timmermans MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Luider TM; Department of Neurology, Erasmus University Medical Center, Rotterdam, the Netherlands., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Umar A; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.; Postgraduate School of Molecular Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Publikováno v:
Proteomics [Proteomics] 2017 Mar; Vol. 17 (5).
Autor:
De Marchi T; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: t.demarchi@erasmusmc.nl., Liu NQ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: n.liu@ncmls.ru.nl., Stingl C; Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: c.stingl@erasmusmc.nl., Timmermans MA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: a.timmermans@erasmusmc.nl., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: m.smid@erasmusmc.nl., Look MP; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: m.look@erasmusmc.nl., Tjoa M; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: milatjoa@hotmail.com., Braakman RB; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Postgraduate School of Molecular Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. Electronic address: r.braakman@erasmusmc.nl., Opdam M; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: m.opdam@nki.nl., Linn SC; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. Electronic address: s.linn@nki.nl., Sweep FC; Department of Laboratory Medicine, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: f.sweep@labgk.umcn.nl., Span PN; Department of Radiation Oncology, Radboud University Medical Center, PO Box 9101, NL-6500 HB, Nijmegen, The Netherlands. Electronic address: P.Span@rther.umcn.nl., Kliffen M; Department of Pathology, Maasstad Hospital, Maasstadweg 21, 3079 DZ, Rotterdam, The Netherlands. Electronic address: KliffenM@maasstadziekenhuis.nl., Luider TM; Department of Neurology, Erasmus MC, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: t.luider@erasmusmc.nl., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: j.foekens@erasmsumc.nl., Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands; Cancer Genomics Center Netherlands, Amsterdam, The Netherlands. Electronic address: j.martens@erasmusmc.nl., Umar A; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Wytemaweg 80, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. Electronic address: a.umar@erasmsumc.nl.
Publikováno v:
Molecular oncology [Mol Oncol] 2016 Jan; Vol. 10 (1), pp. 24-39. Date of Electronic Publication: 2015 Aug 07.
Autor:
Burke K; Department of Biomedical Engineering, University of Rochester, 207 Robert B. Goergen Hall, Box 270168, Rochester, NY, 14627, USA. Kathleen_Burke@URMC.Rochester.edu., Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. M.smid@erasmusmc.nl., Dawes RP; Neuroscience Graduate Program, University of Rochester, 601 Elmwood Ave, Rochester, NY, 14642, USA. Ryan_Dawes@URMC.Rochester.edu., Timmermans MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. M.look@erasmusmc.nl., Salzman P; Department of Biostatistics and Computational Biology, University of Rochester, 601 Elmwood Ave, Rochester, NY, 14642, USA. Psalzman@bst.rochester.edu., van Deurzen CH; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands. C.h.m.vandeurzen@erasmusmc.nl., Beer DG; Departments of Surgery and Radiation Oncology, University of Michigan, Ann Arbor, MI, 48109, USA. Dgbeer@umich.edu., Foekens JA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. J.foekens@erasmusmc.nl., Brown E; Department of Biomedical Engineering, University of Rochester, 207 Robert B. Goergen Hall, Box 270168, Rochester, NY, 14627, USA. Edward_Brown@URMC.Rochester.edu.; Department of Neurobiology and Anatomy, University of Rochester, 601 Elmwood Ave, Rochester, NY, 14642, USA. Edward_Brown@URMC.Rochester.edu.
Publikováno v:
BMC cancer [BMC Cancer] 2015 Nov 24; Vol. 15, pp. 929. Date of Electronic Publication: 2015 Nov 24.
Autor:
Braakman RB; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam , Be401, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands., Bezstarosti K, Sieuwerts AM, de Weerd V, van Galen AM, Stingl C, Luider TM, Timmermans MA, Smid M, Martens JW, Foekens JA, Demmers JA, Umar A
Publikováno v:
Journal of proteome research [J Proteome Res] 2015 Mar 06; Vol. 14 (3), pp. 1627-36. Date of Electronic Publication: 2015 Feb 02.